Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy

Cardiotoxicity is a major complication of anthracycline therapy that negatively impacts prognosis. Effective pharmacotherapies for prevention of anthracycline-induced cardiomyopathy (AICM) are currently lacking. Increased plasma levels of the neutrophil-derived enzyme myeloperoxidase (MPO) predict o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nettersheim, Felix Sebastian, Schlüter, Johannes David, Kreuzberg, Wiebke, Mehrkens, Dennis, Grimm, Simon, Nemade, Harshal, Braumann, Simon, Hof, Alexander, Guthoff, Henning, Peters, Vera, Hoyer, Friedrich Felix, Kargapolova, Yulia, Lackmann, Jan-Wilm, Müller, Stefan, Pallasch, Christian P., Hallek, Michael, Sachinidis, Agapios, Adam, Matti, Winkels, Holger, Baldus, Stephan, Geißen, Simon, Mollenhauer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474188/
https://www.ncbi.nlm.nih.gov/pubmed/37656254
http://dx.doi.org/10.1007/s00395-023-01006-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474188/
https://www.ncbi.nlm.nih.gov/pubmed/37656254
http://dx.doi.org/10.1007/s00395-023-01006-0

Ejemplares similares